MIR518E: A Potential Drug Target and Biomarker (G574487)

Target Name: MIR518E

NCBI ID: G574487

MIR518E

MIR518E: A Potential Drug Target and Biomarker

MicroRNA-518E (miRNA-518E) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and biochemical properties make it an attractive target for drug development.

MiRNA-518E is a small molecule that contains 20 amino acid residues. It is primarily expressed in the brain and has been shown to play a role in various brain functions, including cell survival, proliferation, and differentiation. Its expression is also downregulated in various diseases, including cancer, which suggests that targeting miRNA-518E may be a promising strategy for cancer treatment.

One of the key reasons why miRNA-518E is considered a potential drug target is its involvement in the regulation of cell proliferation. miRNA-518E has been shown to inhibit the proliferation of various cancer cell types, including breast, lung, and ovarian cancer cells. This suggests that targeting miRNA-518E may be an effective way to treat these cancers.

Another potential drug target for miRNA-518E is its role in cell survival. miRNA-518E has been shown to promote the survival of various cancer cell types, including cancer cells, which suggests that targeting miRNA-518E may be an effective way to prevent cancer cell death.

MiRNA-518E is also a potential biomarker for various diseases, including cancer. Its downregulation in cancer cells makes it an attractive target for diagnostic tools and cancer therapies. For example, miRNA-518E has been used as a biomarker for breast cancer, and its expression has been shown to be downregulated in various breast cancer subtypes. This suggests that targeting miRNA-518E may be an effective way to diagnose and treat breast cancer.

In conclusion, miRNA-518E is a promising drug target and biomarker for various diseases, including cancer. Its unique structure and biochemical properties make it an attractive target for drug development. Further research is needed to fully understand the effects of miRNA-518E on cancer cell growth and survival, as well as its potential as a biomarker for various diseases.

Protein Name: MicroRNA 518e

The "MIR518E Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR518E comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets